Fumaric Acid

Fumaric Acid

SCHEMBL9807342

Cc1nc2ccccn2c(=O)c1CCN1CCCC(Nc2nc3cncnc3n2Cc2ccc(F)cc2)CC1.O=C(O)C=CC(=O)O.O=C(O)C=CC(=O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 2/20 0.50
HTR1A known ✓ P08908 2/20 0.50
HTR2C known ✓ P28335 2/20 0.50
KMT2A known ✓ Q03164 2/20 0.50
KCNH2 known ✓ Q12809 5/20 0.43
HRH1 known ✓ P35367 2/20 0.41
MLNR known ✓ O43193 1/20 0.41
CACNA1F known ✓ O60840 1/20 0.41
EGFR known ✓ P00533 1/20 0.41
ERBB2 known ✓ P04626 1/20 0.41
CHRM2 known ✓ P08172 1/20 0.41
ADRB1 known ✓ P08588 1/20 0.41
ADRA2A known ✓ P08913 1/20 0.41
DRD2 known ✓ P14416 1/20 0.41
ADRA2B known ✓ P18089 1/20 0.41
ADRA2C known ✓ P18825 1/20 0.41
CHRM3 known ✓ P20309 1/20 0.41
DRD1 known ✓ P21728 1/20 0.41
SLC6A2 known ✓ P23975 1/20 0.41
ADRA1D known ✓ P25100 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9691198 0.95 CYP3A4 (0.51) CYP3A4CYP2D6SMN1; SMN2MEN1HTR1A
Hydrochloric Acid SCHEMBL9800689 0.83 HTR1A (0.54) CYP3A4CYP2D6SMN1; SMN2MEN1HTR1A
SCHEMBL9564997 0.81 CYP3A4 (0.47) CYP3A4CYP2D6SMN1; SMN2MEN1HTR1A
SCHEMBL9564945 0.80 CYP3A4 (0.54) CYP3A4CYP2D6SMN1; SMN2MEN1HTR1A
SCHEMBL9564879 0.79 CYP3A4 (0.53) CYP3A4CYP2D6SMN1; SMN2MEN1HTR1A
Fumaric Acid SCHEMBL9565032 0.78 SSTR5 (0.45) CYP3A4CYP2D6SMN1; SMN2MEN1HTR1A
Fumaric Acid SCHEMBL9565040 0.75 SSTR5 (0.46) CYP3A4CYP2D6SMN1; SMN2MEN1HTR1A
Fumaric Acid SCHEMBL9631171 0.74 HTR1A (0.45) CYP3A4CYP2D6SMN1; SMN2MEN1HTR1A
SCHEMBL9865735 0.74 KCNH2 (0.58) CYP3A4CYP2D6SMN1; SMN2MEN1HTR1A
SCHEMBL9601699 0.74 SSTR5 (0.52) CYP3A4CYP2D6SMN1; SMN2MEN1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5071846-A Anti-hystaminic [(bicyclic heterocyclyl) methyl and --hetero] substituted hexahydro-1H-azepines and pyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 1991-12-10 US disclosed
US-4988689-A Antiallergens, antihistamines JANSSEN PHARMACEUTICA N.V. (BE) 1991-01-29 US disclosed